You searched for "products"
The polyp shrinker
Inflammatory markers, including T2 cells beta common (βc) cytokines IL-3, IL5 and granulocyte-macrophage colony-stimulating factor (GM-CSF), are known to play an important role in chronic rhinosinusitis with nasal polyps (CRSwNP). CSL311, a monoclonal antibody (mAb), was developed to target human...
Remembering how to speak
Reminiscence therapy (RT) is an approach that provides people with dementia opportunities to recount nostalgic memories and access thoughts for communication. It is one of the most commonly used therapies in aged care settings. The aim of RT is to...
The electromagnetic larynx
Current treatment options for a bilateral vocal cord palsy (tracheostomy, posterior cordotomy, arytenoidectomy) are suboptimal, with a focus primarily on a static means of airway restoration at the expense of voice production and potentially swallow safety. This paper reports on...Developmental stuttering: a speech-motor impairment with sensory aspects
In treating patients who stutter, understanding the effects of sensory input (i.e. auditory input) can help to direct therapeutic approaches. Sensory processing has been identified as a contributory factor in several diagnoses, notably autism and ADHD [1], however it has...saniVENT - sanitizing air-exchanging system from Puma Soundproofing
Puma Soundproofing design, test and manufacture certified soundproof booths for professionals in the medical field.Carleton Medical Ltd, continuation of Lumenis CO2 support
In line with the announcement from Boston Scientific informing customers that they will cease global production of the Lumenis range of CO2 lasers at the end of 2024, Carleton Medical Ltd wish to reassure continuation of service.
